119 related articles for article (PubMed ID: 12143154)
21. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
[TBL] [Abstract][Full Text] [Related]
22. Pharmacodynamic monitoring of the conversion of cyclosporine to tacrolimus in heart and lung transplant recipients.
Barten MJ; Rahmel A; Garbade J; Bold A; Bittner HB; Dhein S; Mohr FW; Gummert JF
Transplant Proc; 2005 Dec; 37(10):4532-4. PubMed ID: 16387162
[TBL] [Abstract][Full Text] [Related]
23. A randomized controlled trial of tacrolimus versus cyclosporine after lung transplantation.
Hachem RR; Yusen RD; Chakinala MM; Meyers BF; Lynch JP; Aloush AA; Patterson GA; Trulock EP
J Heart Lung Transplant; 2007 Oct; 26(10):1012-8. PubMed ID: 17919621
[TBL] [Abstract][Full Text] [Related]
24. Amiodarone-sirolimus/tacrolimus interaction in a pediatric heart transplant patient.
Nalli N; Stewart-Teixeira L; Dipchand AI
Pediatr Transplant; 2006 Sep; 10(6):736-9. PubMed ID: 16911499
[TBL] [Abstract][Full Text] [Related]
25. Impairment of renal function after islet transplant alone or islet-after-kidney transplantation using a sirolimus/tacrolimus-based immunosuppressive regimen.
Andres A; Toso C; Morel P; Demuylder-Mischler S; Bosco D; Baertschiger R; Pernin N; Bucher P; Majno PE; Bühler LH; Berney T
Transpl Int; 2005 Nov; 18(11):1226-30. PubMed ID: 16221151
[TBL] [Abstract][Full Text] [Related]
26. Statins' dosage in patients with renal failure and cyclosporine drug-drug interactions in transplant recipient patients.
Launay-Vacher V; Izzedine H; Deray G
Int J Cardiol; 2005 May; 101(1):9-17. PubMed ID: 15860377
[TBL] [Abstract][Full Text] [Related]
27. Frequency of hyperuricemia and effect of calcineurin inhibitors on serum uric acid levels in liver transplanted children.
Tumgor G; Arikan C; Kilic M; Aydogdu S
Pediatr Transplant; 2006 Sep; 10(6):665-8. PubMed ID: 16911488
[TBL] [Abstract][Full Text] [Related]
28. Sirolimus: new preparation. No tangible advance in renal transplantation.
Prescrire Int; 2002 Dec; 11(62):165-6. PubMed ID: 12469693
[TBL] [Abstract][Full Text] [Related]
29. Cardiac transplantation without calcineurin inhibitors. Sirolimus as first immunosuppressive line. Based on one case.
Lage E; Cabezón S; Hinojosa R; Ordóñez A; Campos A
Transpl Int; 2006 Jan; 19(1):84. PubMed ID: 16359382
[No Abstract] [Full Text] [Related]
30. Relative risk of new-onset diabetes during the first year after renal transplantation in patients receiving tacrolimus or cyclosporine immunosuppression.
Hoitsma AJ; Hilbrands LB
Clin Transplant; 2006; 20(5):659-64. PubMed ID: 16968494
[TBL] [Abstract][Full Text] [Related]
31. Long term efficacy of simvastatin in renal transplant recipients treated with cyclosporine or tacrolimus.
Imamura R; Ichimaru N; Moriyama T; Shi Y; Namba Y; Nonomura N; Matsumiya K; Toki K; Takahara S; Okuyama A
Clin Transplant; 2005 Oct; 19(5):616-21. PubMed ID: 16146552
[TBL] [Abstract][Full Text] [Related]
32. [Pro- and antitumor effects of the main immunosuppressive drugs used in the clinical practice of transplantation].
Marchini F
G Ital Nefrol; 2007; 24(2):171. PubMed ID: 17458835
[No Abstract] [Full Text] [Related]
33. A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function.
Watson CJ; Gimson AE; Alexander GJ; Allison ME; Gibbs P; Smith JC; Palmer CR; Bradley JA
Liver Transpl; 2007 Dec; 13(12):1694-702. PubMed ID: 18044728
[TBL] [Abstract][Full Text] [Related]
34. Dyslipidemia in renal transplant recipients treated with a sirolimus and cyclosporine-based immunosuppressive regimen: incidence, risk factors, progression, and prognosis.
Chueh SC; Kahan BD
Transplantation; 2003 Jul; 76(2):375-82. PubMed ID: 12883196
[TBL] [Abstract][Full Text] [Related]
35. Sirolimus in pediatric patients: results in the first 6 months post-renal transplant.
Hymes LC; Warshaw BL
Pediatr Transplant; 2005 Aug; 9(4):520-2. PubMed ID: 16048606
[TBL] [Abstract][Full Text] [Related]
36. Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low-dose calcineurin inhibitor regimens.
DuBay D; Smith RJ; Qiu KG; Levy GA; Lilly L; Therapondos G
Liver Transpl; 2008 May; 14(5):651-9. PubMed ID: 18433069
[TBL] [Abstract][Full Text] [Related]
37. Diabetes mellitus after transplant: relationship to pretransplant glucose metabolism and tacrolimus or cyclosporine A-based therapy.
Sato T; Inagaki A; Uchida K; Ueki T; Goto N; Matsuoka S; Katayama A; Haba T; Tominaga Y; Okajima Y; Ohta K; Suga H; Taguchi S; Kakiya S; Itatsu T; Kobayashi T; Nakao A
Transplantation; 2003 Nov; 76(9):1320-6. PubMed ID: 14627910
[TBL] [Abstract][Full Text] [Related]
38. Assessing the relative risk of cardiovascular disease among renal transplant patients receiving tacrolimus or cyclosporine.
Jardine AG
Transpl Int; 2005 Apr; 18(4):379-84. PubMed ID: 15773954
[TBL] [Abstract][Full Text] [Related]
39. Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence.
Vivarelli M; Cucchetti A; La Barba G; Ravaioli M; Del Gaudio M; Lauro A; Grazi GL; Pinna AD
Ann Surg; 2008 Nov; 248(5):857-62. PubMed ID: 18948815
[TBL] [Abstract][Full Text] [Related]
40. Glucose and leucine metabolism in lung tranplanted patients on low dose of steroids for immunosuppressive therapy.
Benedini S; Ruffini E; Terruzzi I; Mancuso M; Luzi L
Transplant Proc; 2008 Jun; 40(5):1566-71. PubMed ID: 18589153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]